- cafead   Aug 04, 2023 at 12:22: PM
via Agios Pharmaceuticals has signed a license agreement with Alnylam Pharmaceuticals for preclinical Small interfering RNA (siRNA) development candidate to treat polycythemia vera (PV).
article source
article source